PPARGC1A and Parkinson disease: Functional studies in animal or cell culture models implicate PGC-1α in clinically distinct neurodegenerative diseases including Huntington’s disease (HD), Parkinson’s disease (PD), Alzheimer’s disease (AD), and amyotrophic lateral sclerosis (ALS) [15,16,17,18,19].